Chlorogenic acid prevents inflammatory responses in IL‑1β‑stimulated human SW‑1353 chondrocytes, a model for osteoarthritis

Mol Med Rep. 2017 Aug;16(2):1369-1375. doi: 10.3892/mmr.2017.6698. Epub 2017 Jun 6.

Abstract

Chlorogenic acid (CGA), which is a natural compound found in various plants, has been reported to exert notable anti‑inflammatory activities. The present study investigated the effects and underlying mechanism of CGA on interleukin (IL)‑1β‑induced osteoarthritis (OA) chondrocytes. An in vitro OA‑like chondrocyte model was established using IL‑1β‑stimulated human SW‑1353 chondrocytes. Cell viability was assessed using an MTT assay. Nitric oxide (NO) and IL‑6 production were evaluated by Griess reaction and ELISA, respectively. The expression levels of inducible nitric oxide synthase (iNOS), prostaglandin E2 (PGE2), cyclooxygenase 2 (COX‑2), collagen II, matrix metalloproteinase (MMP)‑13, p65 nuclear factor (NF)‑κB and inhibitor‑κBα were detected by western blot analysis. The results indicated that CGA reversed IL‑1β‑induced increases in iNOS/NO, IL‑6, MMP‑13 and COX‑2/PGE2 production, and reversed the IL‑1β‑mediated downregulation of collagen II. In addition, the data suggested that CGA was capable of inhibiting the IL‑1β‑induced inflammatory response, at least partially via the NF‑κB signaling pathway. In conclusion, CGA may be considered a suitable candidate agent in the treatment of OA.

MeSH terms

  • Cell Line
  • Cell Survival / drug effects
  • Chlorogenic Acid / chemistry
  • Chlorogenic Acid / pharmacology*
  • Chondrocytes / drug effects
  • Chondrocytes / metabolism
  • Chondrocytes / pathology*
  • Collagen Type II / metabolism
  • Cyclooxygenase 2 / metabolism
  • Dinoprostone / metabolism
  • Humans
  • Inflammation / pathology*
  • Inflammation / prevention & control*
  • Interleukin-1beta / toxicity*
  • Interleukin-6 / metabolism
  • Matrix Metalloproteinase 13
  • Models, Biological*
  • NF-KappaB Inhibitor alpha / metabolism
  • NF-kappa B / metabolism
  • Nitric Oxide / metabolism
  • Nitric Oxide Synthase Type II / metabolism
  • Osteoarthritis / metabolism
  • Osteoarthritis / pathology*
  • Signal Transduction / drug effects

Substances

  • Collagen Type II
  • Interleukin-1beta
  • Interleukin-6
  • NF-kappa B
  • NF-KappaB Inhibitor alpha
  • Chlorogenic Acid
  • Nitric Oxide
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2
  • MMP13 protein, human
  • Matrix Metalloproteinase 13
  • Dinoprostone